Investing in digital health and wellness apps
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and therapeutics. Our previous posts on this topic haven’t included digital health and wellness apps, but these consumer-facing products certainly play an important role in transforming healthcare and democratizing its access. The consumerization of healthcare through apps continues to pick up […]
Investing in biotech and therapeutics
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have come from startups in biotech, specifically companies developing therapeutics. From non-hormonal contraceptives that work for men and women to muscle-promoting gene therapy, the potential impact of these new drugs is both immeasurable and inspiring. So, it comes as no surprise […]
Q4 2018: Portfolio News and Activities
We are well into 2019. And yes, this is the time of year when people are thinking about resolutions and looking ahead. And while we are very excited about the new year and new fund, we also want to spend a few minutes to reflect on last quarter. Q4 was an important quarter for our […]
Our Top Posts from 2018
Happy new year! Each week we like share our thoughts on a range of topics from vertical markets to general startup advice and our reflections on investing. We’re proud to say that we wrote a blog post every week in 2018 – and we’ve done that now for the past three years. In case you […]
2018: Year in review and a look ahead
2018 was a big year for Version One, and it’s hard to believe another year is drawing to a close. We invested in seven new companies and participated in many follow-on rounds. Of the new investments, one is in encryption, one is in security, one is in consumer hardware, one is in bio/healthcare, and three […]